Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests".

HJRES 145 is a joint resolution seeking congressional disapproval of a specific FDA rule regarding medical tests developed in laboratories (LDTs). It targets the FDA's May 2024 rule (89 Fed. Reg. 37286) that would have regulated these tests as medical devices. The resolution uses the Congressional Review Act (Chapter 8 of Title 5, U.S. Code) to block the rule from taking effect, stating it "shall have no force or effect." This resolution directly affects the FDA's regulatory authority over laboratory-developed medical tests but does not change existing medical device laws.